This inventor holds 1 USPTO granted patent and 9 published patent applications. Top assignee: Abbvie Inc.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: **Inventor Spotlight: Georgeen Gaza-Bulseco**
Introduction
Georgeen Gaza-Bulseco is a prominent inventor located in Princeton, MA, who has made significant contributions to the field of biochemistry. With her innovative approach, she has successfully developed a patent that addresses critical challenges in drug development and disease treatment.
Latest Patents
Gaza-Bulseco holds one patent titled "Glycoengineered Binding Protein Compositions." This groundbreaking invention includes glycoengineered populations of Fc domain-containing binding proteins designed with a reduced anti-drug immune response (ADA). Additionally, the patent outlines methods for treating diseases using these compositions as well as techniques and hosts for their production.
Career Highlights
Georgeen works at AbbVie Inc., a global biopharmaceutical company dedicated to developing advanced treatments for complex diseases. Her work demonstrates a commitment to innovation and excellence in therapeutic development, making her a valuable asset within the industry.
Collaborations
Throughout her career, Gaza-Bulseco has collaborated with talented colleagues, including Boris Labkovsky and Tariq Ghayur. These partnerships have paved the way for further advancements and research in the medical field, illustrating the importance of teamwork in achieving innovative solutions.
Conclusion
Georgeen Gaza-Bulseco's contributions to science are a testament to the impact of innovation in healthcare. Her patent on glycoengineered binding proteins not only enhances the understanding of drug responses but also represents a significant step forward in the treatment of diseases. Her ongoing work at AbbVie Inc. continues to inspire future advancements in biopharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
